From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy

R J A Veltrop*, M M Kukk, K Topouzidou, L Didden, A Muchir, F G van Steenbeek, L J Schurgers, M Harakalova

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

Severe cardiac remodeling leading to heart failure in individuals harboring pathogenic LMNA variants, known as cardiolaminopathy, poses a significant clinical challenge. Currently, there is no effective treatment for lamin-related diseases. Exploring the intricate molecular landscape underlying this condition, with a specific focus on abnormal mechanotransduction, will propel our understanding of cardiolaminopathy. The LMNA gene undergoes alternative splicing to create A-type lamins, a part of the intermediate filament protein family. A-type lamins are located underneath the nuclear envelope, and given their direct interaction with chromatin, they serve as mechanosensory of the cell by interacting with the cytoskeleton and safeguarding the transcriptional program of cells. Nucleated cells in the cardiovascular system depend on precise mechanical cues for proper function and adaptation to stress. Mechanosensitive signaling pathways are essential in regulating mechanotransduction. They play a pivotal role in various molecular and cellular processes and commence numerous downstream effects, leading to transcriptional activation of target genes involved in proliferation, migration, and (anti-)apoptosis. Most pathways are known to be regulated by kinases, and this area remains largely understudied in cardiomyopathies.Heart failure is linked to disrupted mechanotransduction, where LMNA mutations affect nuclear integrity, impacting the response to extracellular matrix signals and the environment. The Hippo pathway, anchored by YAP1/WWTR1, emerges as a central player by orchestrating cellular responses to mechanical signals. However, the involvement of Hippo and YAP1/WWTR1 in cardiolaminopathy is unclear and likely mutation- and tissue-specific, warranting further investigation. Here, we highlight the involvement of multiple signaling pathways in mechanotransduction in cardiolaminopathy. We delve into (non-)canonical functions of key signaling components, which may hold critical clues for understanding disease pathogenesis. In summary, we comprehensively examine the mechanobiology of A-type lamins, the role of mechanosensitive signaling pathways, and their intricate interplay in the pathogenesis of cardiolaminopathy. A better understanding of these mechanisms is paramount for developing targeted therapies and interventions for individuals afflicted with this debilitating cardiac condition. Prior studies overlooked accurate gene nomenclature in protein and pathway names. Our review addresses this gap, ensuring precision by aligning names with correct gene nomenclature.
Original languageEnglish
Article number197
Number of pages17
JournalCell Communication and Signaling
Volume22
Issue number1
DOIs
Publication statusPublished - 27 Mar 2024

Keywords

  • Cardiolaminopathy
  • Dynamic reciprocity
  • Kinase activity
  • Mechanobiochemistry
  • Mechanotransduction pathways
  • Humans
  • Mechanotransduction, Cellular
  • Lamin Type A/genetics metabolism
  • Cardiomyopathies/genetics metabolism
  • Mutation/genetics
  • Heart Failure/genetics
  • Biophysics

Fingerprint

Dive into the research topics of 'From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy'. Together they form a unique fingerprint.

Cite this